Comparing quality of life between people who use injectable disease modifying therapies and those who switch to oral therapies: A studdy from the Pacific Northwest Multiple Sclerosis (PNWMS) Registry

Authors

• tamela stuchiner, Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Providence Health & Services, Portland, OR, USAFollow
• Lindsay Lucas, Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, USAFollow
• Elizabeth Baraban, Providence Brain and Spine InstituteFollow
• Chiayi Chen, Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, USAFollow
• Alden Smith
• Lobat Hashemi
• Stanley Cohan, Providence Multiple Sclerosis Center, USA.Follow

Document Type

Presentation

Publication Date

2017

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences